You are here

Article info

Article menu
Evidence based practice
Research
Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports

Authors

  1. Correspondence to Dr Tom Jefferson, The Cochrane Collaboration, Via Puglie 23, Roma 00187, Italy; jefferson.tom{at}gmail.com
View Full Text

Citation

Jefferson T, Jones MA, Doshi P, et al
Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports
BMJ Open 2014;4:e005253. doi: 10.1136/bmjopen-2014-005253

Publication history

  • Received March 14, 2014
  • Revised September 3, 2014
  • Accepted September 5, 2014
  • First published September 30, 2014.
Online issue publication 
September 30, 2014
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/